Latest News
Simple and sensitive miRNA labeling in less than two hours
MADISON, Wis., December 19, 2005 - Mirus Bio Corporation announces a break-through approach to miRNA analysis; the Label IT® miRNA Labeling Kit. This kit provides state-of-the-art sensitivity in a rapid one-step reaction format based on Mirus’ proprietary direct alkylation chemistry. The simple kit protocol can be completed in only two hours yielding miRNA samples labeled with Cy™ 3 and Cy™ 5 dyes ready for analysis using popular microarray formats.
The study of miRNA regulation is one of the fastest growing areas of life science research. Scientists need faster and more powerful tools to facilitate their studies. The Label IT® technology will enable scientists to do miRNA microarray studies the same day, versus two days required for other methodologies,” explains Richard Schifreen, Ph.D. vice president of the research products division. Furthermore, “the method offers unequaled sensitivity and avoids the need to add additional bases inherent with enzymatic labeling methods” adds Jim Hagstrom, Ph.D. co-founder and vice president of scientific operations.
About Mirus Bio Corporation:
At Mirus Bio we create tools that enable breakthroughs in life science research and human therapeutics. Established in 1995, the company is internationally recognized as the leader in delivery methods for the emerging fields of gene therapy and RNA interference. We also offer transfection reagents, labeling kits and tools for generating in vivo animal models based on the technology developed within our own therapeutic programs. Our lead program is a collaboration with Transgene S.A. (Strasbourg, France) to develop the MyoDys® gene therapeutic for muscular dystrophy utilizing Mirus’ proprietary Pathway IV ™ delivery technology.
Return to Press Releases
© 2008 Mirus Bio Corporation. All Rights Reserved.